See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Tzu-Fei Wang

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	36775414	0	Alsehly AA, Wang TF, Carrier M. Time to rethink extended thromboprophylaxis after cancer surgery? J Thromb Haemost. 2023 Feb;21(2):198-199. doi: 10.1016/j.jtha.2022.11.015.
	36696186	0	Caiano LM, Drury T, Zahrai A, et al. Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)18246-2. doi: 10.1016/j.jtha.2022.12.008.
	36696183	0	Aziz J, Wang TF, Siegal D, et al. Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer. J Thromb Haemost. 2022 Dec 27:S1538-7836(22)18255-3. doi: 10.1016/j.jtha.2022.12.016.
	36485108	0	Wang TF, Carrier M. The 5 most frequently asked questions about factor Xa inhibitors. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):515-521. doi: 10.1182/hematology.2022000385.
	36217296	0	Wang TF, Sanfilippo KM, Douketis J, et al. Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH. J Thromb Haemost. 2022 Sep 26. doi: 10.1111/jth.15896.
	36210563	0	Wang TF. Drug-drug interactions: Implications for anticoagulation, with focus in patients with cancer. Thromb Res. 2022 May;213 Suppl 1:S66-S71. doi: 10.1016/j.thromres.2021.11.026. Epub 2022 May 26.
	36201366	0	Potere N, Barco S, Mahe I, et al. Awareness of Venous Thromboembolism among Patients with Cancer: Preliminary Findings from a Global Initiative for World Thrombosis Day. J Thromb Haemost. 2022 Oct 6. doi: 10.1111/jth.15902.
	36030068	0	Wang TF, Leader A, Sanfilippo KM. Thrombosis and bleeding in hematological malignancy. Best Pract Res Clin Haematol. 2022 Mar;35(1):101353. doi: 10.1016/j.beha.2022.101353. Epub 2022 Jun 16.
	35660801	0	Brandt W, Brown C, Wang TF, et al. Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial. Thromb Res. 2022 May 29;216:8-10. doi: 10.1016/j.thromres.2022.05.014.
	35635332	0	Sanfilippo KM, Wang TF, Carrier M, et al. Standardization of risk prediction model reporting in cancer-associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy. J Thromb Haemost. 2022 May 18. doi: 10.1111/jth.15759.
	35621286	0	Amenyogbe A, Lemire F, Yachnin D, et al. A survey of physician perception and practices regarding pharmacological thromboprophylaxis during chemotherapy for bladder cancer. Can Urol Assoc J. 2022 May 20. pii: cuaj.7865. doi: 10.5489/cuaj.7865.
	35263789	0	Roy DC, Wang TF, Mallick R, et al. GDF-15, hs-TnT and NT proBNP for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy. Thromb Haemost. 2022 Mar 9. doi: 10.1055/a-1792-7720.
	35124234	0	Wang TF, Mallick R, Carrier M, et al. Safety and efficacy of apixaban thromboprophylaxis in ambulatory cancer patients according to renal function: A subgroup analysis of the AVERT trial. Thromb Res. 2022 Jan 31;211:85-87. doi: 10.1016/j.thromres.2022.01.022.
	35028491	0	Sanfilippo KM, Carson KR, Wang TF, et al. Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma. Res Pract Thromb Haemost. 2022 Jan 9;6(1):e12634. doi: 10.1002/rth2.12634. eCollection 2022 Jan.
	34980834	0	Baumann Kreuziger L, Feng M, Bartosic A, et al. A prospective cohort study of catheter-related thrombosis in cancer patients treated with 1 month of anticoagulation after catheter removal. Blood Coagul Fibrinolysis. 2022 Jan 3. pii: 00001721-900000000-98316. doi: 10.1097/MBC.0000000000001122.
	34845714	0	Delluc A, Wang TF. How to treat incidental pulmonary embolism in cancer patients? Recent advances. Kardiol Pol. 2021 Nov 30. pii: VM/OJS/J/87173. doi: 10.33963/KP.a2021.0164.
	34742140	0	Nayak AL, Zahrai A, Mallick R, et al. Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial. Thromb Res. 2021 Oct 26;208:79-82. doi: 10.1016/j.thromres.2021.10.018.
	34715510	0	Li A, Brandt W, Brown C, et al. Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis. Thromb Res. 2021 Oct 24;208:58-65. doi: 10.1016/j.thromres.2021.10.012.
	34668299	0	Wang TF. Survival in patients with cancer-associated thrombosis in relation to anticoagulants: Re-vitalization of warfarin? J Thromb Haemost. 2021 Nov;19(11):2677-2679. doi: 10.1111/jth.15527.
	34662892	0	Carney BJ, Wang TF, Ren S, et al. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multi-center cohort study. Blood Adv. 2021 Oct 18. pii: 477385. doi: 10.1182/bloodadvances.2021005966.
	34662890	0	Woller SC, Stevens SM, Kaplan D, et al. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood Adv. 2021 Oct 18. pii: 477384. doi: 10.1182/bloodadvances.2021005808.
	34572833	0	Wang TF, Khorana AA, Carrier M. Thrombotic Complications Associated with Immune Checkpoint Inhibitors. Cancers (Basel). 2021 Sep 14;13(18). pii: cancers13184606. doi: 10.3390/cancers13184606.
	34535037	0	Mahe I, Agnelli G, Ay C, et al. Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: the API-CAT Study. Thromb Haemost. 2021 Sep 17. doi: 10.1055/a-1647-9896.
	34455706	0	Bosch FTM, Mulder FI, Huisman MV, et al. Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban. J Thromb Haemost. 2021 Aug 29. doi: 10.1111/jth.15516.
	34399433	0	Wang TF, Carrier M, Fournier K, et al. Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis. Thromb Haemost. 2021 Aug 16. doi: 10.1055/a-1588-9155.
	34327825	0	Wang TF, Baumann Kreuziger L, Leader A, et al. Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. J Thromb Haemost. 2021 Aug;19(8):2068-2081. doi: 10.1111/jth.15367.
	34264267	0	Houghton DE, Billett HH, Gaddh M, et al. Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis. Blood Adv. 2021 Jul 27;5(14):2807-2812. doi: 10.1182/bloodadvances.2021004698.
	34175749	0	Knoll W, Fergusson N, Ivankovic V, et al. Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature. Thromb Res. 2021 Aug;204:114-122. doi: 10.1016/j.thromres.2021.06.010. Epub 2021 Jun 19.
	34161655	0	Caiano L, Carrier M, Marshall A, et al. Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 Oct;19(10):2468-2479. doi: 10.1111/jth.15435. Epub 2021 Jul 12.
	34027291	0	Ikesaka R, Siegal D, Mallick R, et al. Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM-Line): A two-center open-label pilot randomized controlled trial. Res Pract Thromb Haemost. 2021 May 5;5(4):e12517. doi: 10.1002/rth2.12517. eCollection 2021 May.
	33862470	0	Baumann Kreuziger L, Gaddh M, Onadeko O, et al. Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study. Thromb Res. 2021 Jun;202:155-161. doi: 10.1016/j.thromres.2021.03.021. Epub 2021 Apr 6.
	33857789	0	Ladha D, Mallick R, Wang TF, et al. Efficacy and safety of apixaban for primary prevention in gastrointestinal cancers: A post-hoc analysis of the AVERT trial. Thromb Res. 2021 Jun;202:151-154. doi: 10.1016/j.thromres.2021.03.013. Epub 2021 Mar 21.
	33275323	0	Wang TF, Billett HH, Connors JM, et al. Approach to Cancer-Associated Thrombosis: Challenging Situations and Knowledge Gaps. Oncologist. 2021 Jan;26(1):e17-e23. doi: 10.1002/onco.13570. Epub 2020 Dec 4.
	33232187	0	Cohen AJ, Boggio L, Billett HH, et al. North American Physician Practice Patterns in the Management of Anticoagulation in Pregnancy. J Womens Health (Larchmt). 2021 Jun;30(6):829-836. doi: 10.1089/jwh.2020.8385. Epub 2020 Nov 24.
	33216354	0	Patel SH, George TL, Wang TF, et al. Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low-molecular-weight heparin. Cancer. 2021 Mar 15;127(6):938-945. doi: 10.1002/cncr.33337. Epub 2020 Nov 20.
	33196511	0	Wang TF, Waller AP, Lin E, et al. A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism. Blood Coagul Fibrinolysis. 2021 Jan 1;32(1):16-22. doi: 10.1097/MBC.0000000000000968.
	33014332	0	Underwood B, Zhao Q, Walker AR, et al. Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia. Int J Hematol Oncol. 2020 Sep 4;9(3):IJH28. doi: 10.2217/ijh-2020-0009.
	32838111	0	Rosovsky RP, Sanfilippo KM, Wang TF, et al. Anticoagulation Practice Patterns in COVID-19: A Global Survey. Res Pract Thromb Haemost. 2020 Jul 9. pii: RTH212414. doi: 10.1002/rth2.12414.
	32575112	0	Carrier M, Wang TF. Direct oral anticoagulants and cancer-associated VTE: good for all, or just some? Blood. 2020 Aug 6;136(6):669-673. doi: 10.1182/blood.2019004177.
	32395827	0	Wang TF, Delluc A. Thromboprophylaxis in patients with multiple myeloma. Br J Haematol. 2020 Aug;190(4):493-494. doi: 10.1111/bjh.16731. Epub 2020 May 12.
	31999063	0	Zwicker JI, Wang TF, DeAngelo DJ, et al. The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH. J Thromb Haemost. 2020 Feb;18(2):278-284. doi: 10.1111/jth.14671.
	31978224	0	Wang TF, Carrier M. How I treat obese patients with oral anticoagulants. Blood. 2020 Mar 19;135(12):904-911. doi: 10.1182/blood.2019003528.
	31748926	0	Sanfilippo KM, Wang TF. Prevention and Treatment of Cancer-Associated Venous Thromboembolism: a Review. Curr Treat Options Cardiovasc Med. 2019 Nov 20;21(11):70. doi: 10.1007/s11936-019-0764-x.
	31727694	0	Mulder FI, Di Nisio M, Ay C, et al. Clinical implications of incidental venous thromboembolism in cancer patients. Eur Respir J. 2020 Feb 6;55(2). pii: 13993003.01697-2019. doi: 10.1183/13993003.01697-2019. Print 2020 Feb.
	31587337	0	Orzel LA, Abel EE, Blais DM, et al. Risk Factors and Outcomes Associated with Prolonged Subtherapeutic Anticoagulation with Bivalirudin: A Retrospective Cohort Study. Pharmacotherapy. 2019 Dec;39(12):1157-1166. doi: 10.1002/phar.2335. Epub 2019 Oct 29.
	31531846	0	Kander EM, Zhao Q, Bhat SA, et al. Venous and arterial thrombosis in patients with haematological malignancy during treatment with ibrutinib. Br J Haematol. 2019 Nov;187(3):399-402. doi: 10.1111/bjh.16209. Epub 2019 Sep 18.
	31379000	0	Sanfilippo KM, Luo S, Wang TF, et al. Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score. Am J Hematol. 2019 Nov;94(11):1176-1184. doi: 10.1002/ajh.25603. Epub 2019 Aug 19.
	31353841	0	Wang TF, Zwicker JI, Ay C, et al. The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH. J Thromb Haemost. 2019 Oct;17(10):1772-1778. doi: 10.1111/jth.14564. Epub 2019 Jul 28.
	31271705	0	Di Nisio M, van Es N, Carrier M, et al. Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study. J Thromb Haemost. 2019 Nov;17(11):1866-1874. doi: 10.1111/jth.14561. Epub 2019 Jul 25.
	31207027	0	Delluc A, Wang TF, Yap ES, et al. Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH. J Thromb Haemost. 2019 Aug;17(8):1247-1252. doi: 10.1111/jth.14478. Epub 2019 Jun 17.
	30442731	0	Streiff MB, Holmstrom B, Angelini D, et al. NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. J Natl Compr Canc Netw. 2018 Nov;16(11):1289-1303. doi: 10.6004/jnccn.2018.0084.
	30278776	0	Moyer GC, Bannow BS, Thornburg C, et al. Venous Thromboembolism: A Survey of Oral Anticoagulant Preferences in the Treatment of Challenging Patient Populations. Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):209S-216S. doi: 10.1177/1076029618804080. Epub 2018 Oct 2.
	30060256	0	Kraaijpoel N, Di Nisio M, Mulder FI, et al. Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study. Thromb Haemost. 2018 Aug;118(8):1439-1449. doi: 10.1055/s-0038-1667001. Epub 2018 Jul 30.
	30046747	0	Wang TF, Li A, Garcia D. Managing thrombosis in cancer patients. Res Pract Thromb Haemost. 2018 May 1;2(3):429-438. doi: 10.1002/rth2.12102. eCollection 2018 Jul.
	29945822	0	Yoo T, Aggarwal R, Wang TF, et al. Presence and degree of residual venous obstruction on serial duplex imaging is associated with increased risk of recurrence and progression of infrainguinal lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2018 Sep;6(5):575-583.e1. doi: 10.1016/j.jvsv.2017.12.059. Epub 2018 Jun 23.
	29460705	0	Phelps MK, Wiczer TE, Erdeljac HP, et al. A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience. J Oncol Pharm Pract. 2019 Jun;25(4):793-800. doi: 10.1177/1078155218757856. Epub 2018 Feb 20.
	29424601	0	Juhl RC, Roddy JVF, Wang TF, et al. Thromboembolic complications following aminocaproic acid use in patients with hematologic malignancies. Leuk Lymphoma. 2018 Oct;59(10):2377-2382. doi: 10.1080/10428194.2018.1434882. Epub 2018 Feb 9.
	29231094	0	Raskob GE, van Es N, Verhamme P, et al. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12.
	27913551	0	Wang TF, Lim W. What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies? Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):714-716. doi: 10.1182/asheducation-2016.1.714.
	26358792	0	Streiff MB, Holmstrom B, Ashrani A, et al. Cancer-Associated Venous Thromboembolic Disease, Version 1.2015. J Natl Compr Canc Netw. 2015 Sep;13(9):1079-95. doi: 10.6004/jnccn.2015.0133.
	25613924	0	Sanfilippo KM, Wang TF, Gage BF, et al. Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data. Thromb Res. 2015 Apr;135(4):616-20. doi: 10.1016/j.thromres.2015.01.012. Epub 2015 Jan 14.